Literature DB >> 2656872

Localization and characterization of the interleukin 1 immunoreactive pool (IL-1 alpha and beta forms) in normal human epidermis.

L Didierjean1, D Salomon, Y Mérot, G Siegenthaler, A Shaw, J M Dayer, J H Saurat.   

Abstract

A panel of polyclonal antisera and monoclonal antibodies (MoAb) raised against recombinant human interleukin 1 alpha (rh IL-1 alpha) and beta (rh IL-1 beta) was used to localize IL-1 pools within epidermal compartments and to characterize the immunoreactive species. Interleukin 1 alpha and beta immunoreactive species were detected by Western blot analysis only when epidermal extracts were obtained in extraction buffers containing dithiothreitol (DTT), sodium dodecyl sulfate (SDS), or 2 mercaptoethanol. Together with the 31-kD (intracellular precursor molecule) and the 17-kD (mature, secreted form) species, most of the antisera and MoAb reacted with a protein of 52-kD that was not found in several internal organs, and from which a 31-kD form could be released upon reelectrophoresis. Interleukin 1 beta immunoreactivity was consistently found by immunohistology at the level of the stratum granulosum, where IL-1 alpha immunoreactivity, although less consistently, also localized. Several monoclonal antibodies to IL-1 beta reacted intensively and specifically with epidermal basal cells. At the electron microscopical level, IL-1 beta immunoreactivity was detected in the upper layers of the stratum granulosum; it appeared to be membrane associated and suggested an exocytosis process similar to that involving lamellar bodies. These observations 1) confirm the presence of IL-1 species in the normal unstimulated human epidermis, 2) show that both IL-1 alpha and beta are detectable herein, 3) identify 52-kD IL-1 alpha and beta immunoreactive bands that appear special to the epidermis, and 4) suggest a link between epidermal IL-1 and the differentiation process of the keratinocyte.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2656872     DOI: 10.1111/1523-1747.ep12696825

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  8 in total

1.  Study of immune-associated antigens (IL-1 and ICAM-1) in normal human keratinocytes treated by sodium lauryl sulphate.

Authors:  H Gatto; J Viac; M Charveron; D Schmitt
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

2.  Cutaneous barrier perturbation stimulates cytokine production in the epidermis of mice.

Authors:  L C Wood; S M Jackson; P M Elias; C Grunfeld; K R Feingold
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

3.  Extraction and quantitation of cytokine mRNA from human epidermal blister roofs.

Authors:  C D Enk; S I Katz
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

4.  Proteolytic activation of the interleukin-1beta precursor by Candida albicans.

Authors:  A Beauséjour; D Grenier; J P Goulet; N Deslauriers
Journal:  Infect Immun       Date:  1998-02       Impact factor: 3.441

5.  Interleukin-1 receptor antagonist in normal and psoriatic epidermis.

Authors:  C Hammerberg; W P Arend; G J Fisher; L S Chan; A E Berger; J S Haskill; J J Voorhees; K D Cooper
Journal:  J Clin Invest       Date:  1992-08       Impact factor: 14.808

6.  Effects of thermal shocks on interleukin-1 levels and heat shock protein 72 (HSP72) expression in normal human keratinocytes.

Authors:  H Gatto; J Viac; M Charveron; D Schmitt
Journal:  Arch Dermatol Res       Date:  1992       Impact factor: 3.017

7.  Permeability barrier disruption alters the localization and expression of TNF alpha/protein in the epidermis.

Authors:  J C Tsai; K R Feingold; D Crumrine; L C Wood; C Grunfeld; P M Elias
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

8.  The role of inflammatory mediators in the pathogenesis of otitis media and sequelae.

Authors:  Steven K Juhn; Min-Kyo Jung; Mark D Hoffman; Brian R Drew; Diego A Preciado; Nicholas J Sausen; Timothy T K Jung; Bo Hyung Kim; Sang-Yoo Park; Jizhen Lin; Frank G Ondrey; David R Mains; Tina Huang
Journal:  Clin Exp Otorhinolaryngol       Date:  2008-09-30       Impact factor: 3.372

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.